cGxP.wire https://validator.w3.org/feed/docs/rss2.html Amylyx Pharmaceuticals Advances Avexitide Toward Phase 3 Data AbCellera to Announce ABCL635 Phase 2 Results FDA Approves Tudriqev for Advanced Refractory Melanoma Biogen Completes RayThera Acquisition to Expand Immunology Praxis Precision Medicines Advances Key Regulatory Programs Blacksmith Medicines Advances Novel Antibiotic Discovery Evotec Expands AI Drug Discovery with Odyssey Partnership X4 Pharmaceuticals Reports Q2 2026 Results and Advances Mavorixafor Development Kiora Pharmaceuticals Advances Key Clinical Programs Caris Life Sciences Advances AI for Breast Cancer Care Astellas Advances Menopause Drug Toward Japan Approval Co-Diagnostics Submits FDA 510(k) for PCR Respiratory Test bioAffinity Technologies Reports CyPath Lung Growth Alebund Pharmaceuticals Gains China NMPA NDA Acceptance Tarsus Pharmaceuticals Expands Eye Care with Alkeus Deal INmune Bio Reports Q2 2026 Results and Pipeline Progress Philips Expands Patient Monitoring Ecosystem with Partnerships BioInvent Receives FDA Fast Track Designation for BI-1808 IceCure Medical Expands ChoICE Study for Breast Cancer Faeth Therapeutics to Present PIKTOR PK/PD Data NRx Pharmaceuticals Clears FDA ANDA Review Aclaris Therapeutics Receives FDA Fast Track for Modzatinib Ractigen Advances Phase II Trial of RAG-17 for SOD1-ALS CancerVax Activates Human Killer T-Cells Against Cancer Reckitt Secures FDA Approval for New Mucinex 12HR Therapy Bavarian Nordic Secures EU Approval for IMVANEX in Children MiNK Therapeutics to Present AgenT-797 Clinical Update Propanc Biopharma Reports Strong Preclinical PRP Results Vivani Medical Completes Phase 1 SLIM-1 Dosing of NPM-139 Implant Annexon Reports Rapid GBS Responses with Tanruprubart in FORWARD Study Vistagen Reports Positive Phase 2 Fasedienol Repeat-Dose Data Ascendis Pharma Shows Positive Long-Term COACH Results Pacira BioSciences Publishes Two-Year Phase 1 PCRX-201 Knee OA Data Medtronic Expands CE Mark for Sphere-9 in Ventricular Ablation WindRose Recapitalizes Verified Clinical Trials to Fuel Growth Theriva Biologics Advances VCN-01 in Pancreatic Cancer Senhwa Wins TFDA Clearance for CX-5461 Immunotherapy Trial BioVie Advances Parkinson’s Program with Phase 2 Success Galibra Neuroscience Wins FDA Designations for SSADH Therapy Agenus Advances Phase 3 ROBBIN Trial for MSS Colon Cancer LifeMine Raises $263M to Advance LIFE-001 Transplant Therapy Phoenix Nest Secures $2.98M to Advance JLK-247 Gene Therapy Merck FDA Accepts ENFLONSIA sBLA for Second RSV Season Vedanta Biosciences Secures $60M to Advance Phase 3 VE303 Olio Labs AI Platform Predicts Human Drug Trial Outcomes Ono Pharma Partners with Mediar to Develop Novel Fibrosis Antibodies CSHL and Northwell Build 150+ Next-Gen Cancer Models Harrow Acquires TYRVAYA Global Rights, Expands Dry Eye Portfolio Kodiak Sciences Advances KSI-101 Phase 3 PEAK Trial Alteogen Signs $365M Global Deal for Hybrozyme Platform